Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35)
- PMID: 25717103
- PMCID: PMC4442513
- DOI: 10.1128/JVI.03434-14
Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35)
Abstract
High-risk human papillomaviruses (HR-HPV) cause anogenital cancers, including cervical cancer, and head and neck cancers. Human papillomavirus 16 (HPV16) is the most prevalent HR-HPV. HPV oncogenesis is driven by two viral oncoproteins, E6 and E7, which are expressed through alternative splicing of a polycistronic RNA to yield four major splice isoforms (E6 full length, E6*I, E6*II, E6*X). The production of multiple mRNA isoforms from a single gene is controlled by serine/arginine-rich splicing factors (SRSFs), and HPV16 infection induces overexpression of a subset of these, SRSFs 1, 2, and 3. In this study, we examined whether these proteins could control HPV16 oncoprotein expression. Small interfering RNA (siRNA) depletion experiments revealed that SRSF1 did not affect oncoprotein RNA levels. While SRSF3 knockdown caused some reduction in E6E7 expression, depletion of SRSF2 resulted in a significant loss of E6E7 RNAs, resulting in reduced levels of the E6-regulated p53 proteins and E7 oncoprotein itself. SRSF2 contributed to the tumor phenotype of HPV16-positive cervical cancer cells, as its depletion resulted in decreased cell proliferation, reduced colony formation, and increased apoptosis. SRSF2 did not affect transcription from the P97 promoter that controls viral oncoprotein expression. Rather, RNA decay experiments showed that SRSF2 is required to maintain stability of E6E7 mRNAs. These data show that SRSF2 is a key regulator of HPV16 oncoprotein expression and cervical tumor maintenance.
Importance: Expression of the HPV16 oncoproteins E7 and E6 drives HPV-associated tumor formation. Although increased transcription may yield increased levels of E6E7 mRNAs, it is known that the RNAs can have increased stability upon integration into the host genome. SR splicing factors (SRSFs) control splicing but can also control other events in the RNA life cycle, including RNA stability. Previously, we demonstrated increased levels of SRSFs 1, 2, and 3 during cervical tumor progression. Now we show that SRSF2 is required for expression of E6E7 mRNAs in cervical tumor but not nontumor cells and may act by inhibiting their decay. SRSF2 depletion in W12 tumor cells resulted in increased apoptosis, decreased proliferation, and decreased colony formation, suggesting that SRSF2 has oncogenic functions in cervical tumor progression. SRSF function can be targeted by known drugs that inhibit SRSF phosphorylation, suggesting a possible new avenue in abrogating HPV oncoprotein activity.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
Figures
![FIG 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4442513/bin/zjv9990903250001.gif)
![FIG 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4442513/bin/zjv9990903250002.gif)
![FIG 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4442513/bin/zjv9990903250003.gif)
![FIG 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4442513/bin/zjv9990903250004.gif)
![FIG 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4442513/bin/zjv9990903250005.gif)
![FIG 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4442513/bin/zjv9990903250006.gif)
![FIG 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4442513/bin/zjv9990903250007.gif)
![FIG 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4442513/bin/zjv9990903250008.gif)
Similar articles
-
High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing Regulation.Front Cell Infect Microbiol. 2022 Jun 27;12:929666. doi: 10.3389/fcimb.2022.929666. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35832386 Free PMC article. Review.
-
Human Papillomavirus Type 16 Circular RNA Is Barely Detectable for the Claimed Biological Activity.mBio. 2022 Feb 22;13(1):e0359421. doi: 10.1128/mbio.03594-21. Epub 2022 Jan 18. mBio. 2022. PMID: 35038914 Free PMC article.
-
Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.J Virol. 2020 Sep 29;94(20):e01509-20. doi: 10.1128/JVI.01509-20. Print 2020 Sep 29. J Virol. 2020. PMID: 32759322 Free PMC article.
-
In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.Antiviral Res. 2020 Jun;178:104794. doi: 10.1016/j.antiviral.2020.104794. Epub 2020 Apr 14. Antiviral Res. 2020. PMID: 32298665
-
Molecular mechanism of carcinogenesis by human papillomavirus-16.J Dermatol. 2000 Feb;27(2):73-86. doi: 10.1111/j.1346-8138.2000.tb02126.x. J Dermatol. 2000. PMID: 10721654 Review.
Cited by
-
HPV and RNA Binding Proteins: What We Know and What Remains to Be Discovered.Viruses. 2024 May 15;16(5):783. doi: 10.3390/v16050783. Viruses. 2024. PMID: 38793664 Free PMC article. Review.
-
Virus usurps alternative splicing to clear the decks for infection.Virol J. 2023 Jun 20;20(1):131. doi: 10.1186/s12985-023-02098-9. Virol J. 2023. PMID: 37340420 Free PMC article. Review.
-
High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing Regulation.Front Cell Infect Microbiol. 2022 Jun 27;12:929666. doi: 10.3389/fcimb.2022.929666. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35832386 Free PMC article. Review.
-
Nuclear speckles - a driving force in gene expression.J Cell Sci. 2022 Jul 1;135(13):jcs259594. doi: 10.1242/jcs.259594. Epub 2022 Jul 5. J Cell Sci. 2022. PMID: 35788677 Free PMC article. Review.
-
Molecular Mechanisms of HIV Protease Inhibitors Against HPV-Associated Cervical Cancer: Restoration of TP53 Tumour Suppressor Activities.Front Mol Biosci. 2022 May 10;9:875208. doi: 10.3389/fmolb.2022.875208. eCollection 2022. Front Mol Biosci. 2022. PMID: 35620479 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous